Mountview Estates PLC (MTVW)
London Exchange · UK · prices in GBX · close of 20 Oct 2026
Key indicators
| Last close | GBX 8,500.00 |
|---|---|
| 52-week range | 8,148.89 – 9,520.24 |
| Return, 1 month / 3 months | −1.7% / −1.2% |
| Return, 1 year / 3 years | −7.0% / −0.9% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 22.3% |
| Worst drawdown (1 year) | -11.7% |
| Average daily value traded | 3.85M GBX |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mountview Estates PLC is a property investment company based in the United Kingdom. It owns and manages a portfolio of residential properties, mainly blocks of flats and houses, concentrated in London and the surrounding areas. Much of its housing stock is let to tenants under regulated or protected tenancy arrangements, and the company generally acquires such properties and holds them for rental income rather than trading them. Its customers are residential tenants occupying its flats and houses.
The shares are listed on the London Exchange in UK under the code MTVW, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mountview Estates PLC (MTVW) trades on the London Exchange in UK. It last closed at GBX 8,500.00 on 20 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,403 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.0% and over the last three months it fell 1.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.6% | ||
| From 52-week high | -8.5% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -1.2% | ||
| 6-month return | -2.0% | ||
| 12-month return, skipping the last month | -5.4% | ||
| Stability (higher is calmer) | 87 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.7% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.85M GBX | ||
| Zero-volume days | 15.0% | ||
| Income | 34 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −1.7% |
| 3 months | −1.2% |
| 6 months | −2.0% |
| 1 year | −7.0% |
| 3 years | −0.9% |
| 5 years | −18.8% |
Signals
| 50-day / 200-day average | 8,702.00 / 8,642.14 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 208.94 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Jul 2026 | GBP 2.7500 |
| 19 Feb 2026 | GBP 2.5000 |
| 10 Jul 2025 | GBP 2.7500 |
| 20 Feb 2025 | GBP 2.5000 |
| 11 Jul 2024 | GBP 2.7500 |
| 15 Feb 2024 | GBP 2.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.